Breadcrumb
Clinical Value Considerations for Gene Therapy in Spinal Muscular Atrophy
Date: Thursday, Jun. 2, 2022, 2-3pm ET
Event Type: Webinars
Price: Member: Free Non-Member: Free
Join us as we explore recent data updates for gene therapy in spinal muscular atrophy (SMA) and gain a deeper understanding of its clinical value.
In this webinar, experts will share and discuss current data pertaining to motor milestone achievement in presymptomatic patients with 3 copies of survival motor neuron 2 (SMN2). The importance of biodistribution and bulbar function will also be discussed.
Speakers:
- Brian Howell, PharmD
Novartis Gene Therapies Regional Medical Director - Nicole LaMarca, DNP
Novartis Gene Therapies Global Medical Director, Data Exploration and Generation Lead
This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
Sponsored by:
For individuals from the media/press who are interested in attending, please email media@amcp.org.